Indication
Airway Inflammation
4 clinical trials
8 products
1 drug
Product
SymbicortClinical trial
A 24-week Randomised Exploratory Open-Label Study Aiming To Characterise Changes In Airway Inflammation, Symptoms, Lung Function, And Reliever Use In Asthma Patients Using SABA (Salbutamol) Or Anti-Inflammatory Reliever (SYMBICORT®) As Rescue Medication In Addition To SYMBICORT As Daily Asthma ControllerStatus: Completed, Estimated PCD: 2022-12-16
Clinical trial
A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti-Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium Dose Mometasone Furoate DPI and MDI Formulations in Adults and Adolescents With Persistent Allergic AsthmaStatus: Completed, Estimated PCD: 2009-06-01
Product
MF DPI 200Product
MF MDIProduct
PlaceboClinical trial
A Phase II Randomized, Double Blinded, Placebo-controlled Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy AdultsStatus: Completed, Estimated PCD: 2023-03-02
Product
Gamma TocopherolDrug
VarlilumabClinical trial
Phase I/II Randomized, Double-blind, Placebo-controlled Cross-over Study of Prednisone on Airway Inflammatory Response to Inhaled Wood SmokeStatus: Completed, Estimated PCD: 2023-05-12
Product
Prednisone